Global African Trypanosomiasis Treatment Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 African Trypanosomiasis Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global African Trypanosomiasis Treatment Market Size Growth Rate by Product
- 1.4.2 MS-08
- 1.4.3 CBL-0137
- 1.4.4 AN-5568
- 1.4.5 GNF-6702
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global African Trypanosomiasis Treatment Market Size Growth Rate by End User
- 1.5.2 Research Center
- 1.5.3 Hospital
- 1.5.4 Clinic
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global African Trypanosomiasis Treatment Market Size
- 2.1.1 Global African Trypanosomiasis Treatment Revenue 2014-2025
- 2.1.2 Global African Trypanosomiasis Treatment Sales 2014-2025
- 2.2 African Trypanosomiasis Treatment Growth Rate by Regions
- 2.2.1 Global African Trypanosomiasis Treatment Sales by Regions
- 2.2.2 Global African Trypanosomiasis Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 African Trypanosomiasis Treatment Sales by Manufacturers
- 3.1.1 African Trypanosomiasis Treatment Sales by Manufacturers
- 3.1.2 African Trypanosomiasis Treatment Sales Market Share by Manufacturers
- 3.1.3 Global African Trypanosomiasis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 African Trypanosomiasis Treatment Revenue by Manufacturers
- 3.2.1 African Trypanosomiasis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 African Trypanosomiasis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 African Trypanosomiasis Treatment Price by Manufacturers
- 3.4 African Trypanosomiasis Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 African Trypanosomiasis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers African Trypanosomiasis Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into African Trypanosomiasis Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global African Trypanosomiasis Treatment Sales by Product
- 4.2 Global African Trypanosomiasis Treatment Revenue by Product
- 4.3 African Trypanosomiasis Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global African Trypanosomiasis Treatment Breakdown Data by End User
6 North America
- 6.1 North America African Trypanosomiasis Treatment by Countries
- 6.1.1 North America African Trypanosomiasis Treatment Sales by Countries
- 6.1.2 North America African Trypanosomiasis Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America African Trypanosomiasis Treatment by Product
- 6.3 North America African Trypanosomiasis Treatment by End User
7 Europe
- 7.1 Europe African Trypanosomiasis Treatment by Countries
- 7.1.1 Europe African Trypanosomiasis Treatment Sales by Countries
- 7.1.2 Europe African Trypanosomiasis Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe African Trypanosomiasis Treatment by Product
- 7.3 Europe African Trypanosomiasis Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific African Trypanosomiasis Treatment by Countries
- 8.1.1 Asia Pacific African Trypanosomiasis Treatment Sales by Countries
- 8.1.2 Asia Pacific African Trypanosomiasis Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific African Trypanosomiasis Treatment by Product
- 8.3 Asia Pacific African Trypanosomiasis Treatment by End User
9 Central & South America
- 9.1 Central & South America African Trypanosomiasis Treatment by Countries
- 9.1.1 Central & South America African Trypanosomiasis Treatment Sales by Countries
- 9.1.2 Central & South America African Trypanosomiasis Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America African Trypanosomiasis Treatment by Product
- 9.3 Central & South America African Trypanosomiasis Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa African Trypanosomiasis Treatment by Countries
- 10.1.1 Middle East and Africa African Trypanosomiasis Treatment Sales by Countries
- 10.1.2 Middle East and Africa African Trypanosomiasis Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa African Trypanosomiasis Treatment by Product
- 10.3 Middle East and Africa African Trypanosomiasis Treatment by End User
11 Company Profiles
- 11.1 Merck & Co Inc
- 11.1.1 Merck & Co Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck & Co Inc African Trypanosomiasis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck & Co Inc African Trypanosomiasis Treatment Products Offered
- 11.1.5 Merck & Co Inc Recent Development
- 11.2 Novartis AG
- 11.2.1 Novartis AG Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis AG African Trypanosomiasis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis AG African Trypanosomiasis Treatment Products Offered
- 11.2.5 Novartis AG Recent Development
- 11.3 Sanofi
- 11.3.1 Sanofi Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi African Trypanosomiasis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi African Trypanosomiasis Treatment Products Offered
- 11.3.5 Sanofi Recent Development
- 11.4 Scynexis Inc
- 11.4.1 Scynexis Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Scynexis Inc African Trypanosomiasis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Scynexis Inc African Trypanosomiasis Treatment Products Offered
- 11.4.5 Scynexis Inc Recent Development
12 Future Forecast
- 12.1 African Trypanosomiasis Treatment Market Forecast by Regions
- 12.1.1 Global African Trypanosomiasis Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global African Trypanosomiasis Treatment Revenue Forecast by Regions 2019-2025
- 12.2 African Trypanosomiasis Treatment Market Forecast by Product
- 12.2.1 Global African Trypanosomiasis Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global African Trypanosomiasis Treatment Revenue Forecast by Product 2019-2025
- 12.3 African Trypanosomiasis Treatment Market Forecast by End User
- 12.4 North America African Trypanosomiasis Treatment Forecast
- 12.5 Europe African Trypanosomiasis Treatment Forecast
- 12.6 Asia Pacific African Trypanosomiasis Treatment Forecast
- 12.7 Central & South America African Trypanosomiasis Treatment Forecast
- 12.8 Middle East and Africa African Trypanosomiasis Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 African Trypanosomiasis Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global African Trypanosomiasis Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the African Trypanosomiasis Treatment market based on company, product type, end user and key regions.
This report studies the global market size of African Trypanosomiasis Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of African Trypanosomiasis Treatment in these regions.
This research report categorizes the global African Trypanosomiasis Treatment market by top players/brands, region, type and end user. This report also studies the global African Trypanosomiasis Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co Inc
Novartis AG
Sanofi
Scynexis Inc
Market size by Product
MS-08
CBL-0137
AN-5568
GNF-6702
Others
Market size by End User
Research Center
Hospital
Clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global African Trypanosomiasis Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of African Trypanosomiasis Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global African Trypanosomiasis Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of African Trypanosomiasis Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of African Trypanosomiasis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of African Trypanosomiasis Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.